Related Experiment Video
Updated: Dec 22, 2025

Visualizing Mitophagy with Fluorescent Dyes for Mitochondria and Lysosome
Published on: November 30, 2022
Mitophagy in cardiovascular disease
Hong Zhou1, Lu He2, Gaosheng Xu3
1Institute of Pharmacy and Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drugs Study, Hengyang Medical College, University of South China, Hengyang 421001, Hunan Province, China; Department of Radiology, The First Affiliated Hospital, University of South China, Hengyang, Hunan Province, China.
Insights
Mitochondria dysfunction contributes to cardiovascular diseases (CVD). Mitophagy, a cellular process, removes damaged mitochondria, and its modulation offers a potential therapeutic strategy for managing CVD.
Area of Science:
- Biomedical Science
- Cardiovascular Research
- Cellular Biology
Background:
- Cardiovascular disease (CVD) is a major global health concern, linked to high morbidity and mortality.
- Mitochondrial dysfunction is increasingly recognized as a key factor in the pathogenesis of various CVDs, including atherosclerosis, hypertension, and heart failure.
- Mitophagy, a selective form of autophagy, plays a crucial role in maintaining mitochondrial quality and cardiac function under stress.
Purpose of the Study:
- To review the latest findings on the mechanistic and functional roles of mitophagy in cardiovascular disease (CVD) pathogenesis.
- To explore the potential of targeting mitophagy as a therapeutic strategy for CVD management.
Main Methods:
- Literature review of recent research on mitophagy and cardiovascular diseases.
- Analysis of the mechanisms underlying mitophagy in cardiac stress and disease conditions.
- Examination of existing and potential therapeutic interventions targeting mitophagy.
Main Results:
- Mitochondrial dysfunction is implicated in a wide range of cardiovascular conditions.
- Mitophagy acts as a critical quality control mechanism to preserve cardiac function during stress.
- Dysregulation of mitophagy is observed in various cardiovascular diseases.
Conclusions:
- Modulating mitophagy pathways presents a promising therapeutic avenue for cardiovascular disease management.
- Understanding mitophagy's role is crucial for developing novel treatments for heart conditions.
- Targeting mitophagy could offer new strategies to combat cardiovascular morbidity and mortality.
Abstract:
Cardiovascular disease (CVD) leads to high morbidity and mortality rates worldwide. Accumulating evidence has revealed that mitochondria dysfunction is implicated in CVD, such as atherosclerosis (AS), hypertension, myocardial ischemia-reperfusion (MI/R) injury, myocardial infarction (MI), cardiac hypertrophy, heart failure (HF), dilated cardiomyopathy (DCM) and so on. Mitophagy is a mitochondrial quality control mechanism that eliminates damaged or superfluous mitochondria to maintain cardiac function in response to various stress and cardiac disease conditions. This article reviews the latest findings regarding the mechanistic, functional, and potential role of mitophagy in the pathogenesis of CVD. Moreover, various drugs can target mitophagy activity during CVD progression. Thus, the modulation of the mitophagy pathway provides a potential therapeutic strategy for CVD management.
More Related Videos
Related Concept Videos
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Coronary Artery Disease II: Pathophysiology
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...

